ONCO — Oncopeptides AB Share News
0.000.00%
Last trade - 00:00- SEK665.09m
- SEK642.65m
- SEK71.12m
Brief: Swedish Watchdog Ends Investigation Of Oncopeptides CSO
Brief: Oncopeptides Posts Q1 Sales of SEK 1.124 Million
Brief: Oncopeptides Q1 Operating Result SEK 72.7 Mln
Brief: Oncopeptides Presents New Scientific Data At European Myeloma Network Meeting
Brief: Oncopeptides Receives Research Grant From Sweden's Innovation Agency
Brief: Oncopeptides CSO Is Released From Custody
Brief: Oncopeptides CSO Suspected Of Market Abuse Act Breach
Brief: Oncopeptides Posts Q4 Net Loss of SEK 91.1 Million
Brief: Oncopeptides Appoints Holger Lembrer As CFO
Brief: Oncopeptides Appoints Monica Shaw As New CEO
Oncopeptides tumbles as FDA withdraws U.S. marketing authorization for Pepaxto
Brief: Oncopeptides Says FDA Requests For Withdrawal Of Authorization For Pepaxto
Brief: Oncopeptides Says Enters Into A Renewed Loan Facility Agreement Of Up To EUR 30 Mln With The European Investment Bank
Brief: Oncopeptides' Pepaxti Has Been Granted Marketing Authorization In The UK
Brief: Oncopeptides Q3 Oper Loss Narrows To SEK 88.9 Mln
Brief: Oncopeptides Announces Market Potential For Pepaxti In Europe
Oncopeptides plummets after FDA ODAC votes against Pepaxto
Brief: Oncopeptides Provides Update From Meeting With FDAs Advisory Committee ODAC
Brief: Oncopeptides Provides An Update From The Meeting With FDA's Advisory Committee ODAC